This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Milestone Pharmaceuticals (Quebec, Canada).
Reference
Sacks NC, et al. Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia. American Journal of Cardiology : 30 Oct 2019. Available from: URL: http://doi.org/10.1016/j.amjcard.2019.10.015
Rights and permissions
About this article
Cite this article
Paroxysmal supraventricular tachycardia large economic burden. PharmacoEcon Outcomes News 843, 26 (2019). https://doi.org/10.1007/s40274-019-6453-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6453-x